A Phase I Safety and Immunogenicity Trial of IHV01 in HIV-1 Uninfected Volunteers
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 07 Aug 2017
At a glance
- Drugs HIV vaccine (Primary)
- Indications HIV infections
- Focus Adverse reactions
- 02 Aug 2017 Planned End Date changed from 1 May 2018 to 1 Jul 2018.
- 02 Aug 2017 Planned primary completion date changed from 1 Dec 2017 to 1 Jul 2018.
- 02 Aug 2017 Status changed from recruiting to active, no longer recruiting.